IGF2BP2 and glioblastoma: RT‒qPCR was used to assess the knockdown efficiency of si-IGF2BP1, si-IGF2BP2, and si-IGF2BP3 siRNAs in LN229R and U251R TMZ-resistant GBM cell lines.